bicalox 50 mg/1 tableta filmom obložena tableta
unifarm d.o.o. - bikalutamid - filmom obložena tableta - 50 mg/1 tableta - 1 filmom obložena tableta sadrži: 50 mg bikalutamid
casodex 50 mg filmom obložene tablete
laboratoires juvisé pharmaceuticals, 149 boulevard bataille de stalingrad, villeurbanne, francuska - bikalutamid - filmom obložena tableta - 50 mg - urbroj: jedna filmom obložena tableta sadrži 50 mg bikalutamida
casodex 150 mg filmom obložene tablete
laboratoires juvisé pharmaceuticals, 149 boulevard bataille de stalingrad, villeurbanne, francuska - bikalutamid - filmom obložena tableta - 150 mg - urbroj: jedna filmom obložena tableta sadrži 150 mg bikalutamida
bicadex 50mg film tableta
pharmaswiss - montenegro, pharmaswiss doo beograd, dio stranog druŠtva u podgorici - bikalutamid - film tableta - 50mg
casodex 150mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - bikalutamid - film tableta - 150mg
casodex 50mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - bikalutamid - film tableta - 50mg
dormicum 15 mg filmom obložene tablete
cheplapharm arzneimittel gmbh, ziegelhof 24, greifswald, njemačka - midazolammaleat - filmom obložena tableta - 15 mg - urbroj: jedna tableta sadrži 15 mg midazolama u obliku midazolammaleata
firmagon
ferring pharmaceuticals a/s - degarelix - prostatske neoplazme - endokrinska terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
xtandi
astellas pharma europe b.v. - enzalutamide - prostatske neoplazme - endokrinska terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
xtandi 40 mg/1 kapsula kapsula, meka
clinres farmacija d.o.o. - enzalutamid - kapsula, meka - 40 mg/1 kapsula - 1 kapsula, meka sadrži: 40 mg enzalutamida